Mesenchymal Stromal Cells in Kidney Transplant Recipients
Autologous Mesenchymal Stromal Cells to Induce Tolerance in Living-donor Kidney Transplant Recipients
Sponsor: A.O. Ospedale Papa Giovanni XXIII
Terminated
Failure to enroll the number of patients required by the protocol due to the low number of living donor transplants performed at the Clinical Center
Other terminated trials from A.O. Ospedale Papa Giovanni XXIII
Other Kidney Transplant Rejection trials with similar outcome
Listed as NCT02012153, this PHASE1 trial focuses on Kidney Transplant Rejection and remains terminated or withdrawn. Sponsored by A.O. Ospedale Papa Giovanni XXIII, it has been updated 10 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jul 2023 — Jul 2024 [monthly]
Terminated PHASE1
Status: Recruiting → Terminated
-
Dec 2021 — Jul 2023 [monthly]
Recruiting PHASE1
-
Jan 2021 — Dec 2021 [monthly]
Recruiting PHASE1
▶ Show 5 earlier versions
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Oct 2020 — Dec 2020 [monthly]
Recruiting PHASE1
-
Aug 2019 — Oct 2020 [monthly]
Recruiting PHASE1
-
Jun 2018 — Aug 2019 [monthly]
Recruiting PHASE1
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- A.O. Ospedale Papa Giovanni XXIII
- Mario Negri Institute for Pharmacological Research
For direct contact, visit the study record on ClinicalTrials.gov .